MillerRussel R.: Drug Surveillance Utilizing Epidemiologic Methods, Amer. J. Hosp. Pharm.30: 584 (July) 1973.
2.
CaranasosG. J.StewartR. B.CluffL. E.: Drug-Induced Illness Leading to Hospitalization, J. Amer, Med. Assoc.228: 6: 713 (May 6) 1974.
3.
ShapiroSamuelSloneD.LewisG. P.JickH.: Fatal Drug Reactions Among Medical Inpatients, J. Amer. Med. Assoc.216: 3: 467 (Apr. 19) 1971.
4.
Editorial, Disease Drugs Cause. New Engl. J. Med.279: 23: 1286 (Dec. 5) 1968.
5.
Drug Research Board, Division of Medical Sciences, National Research Council: Report of the International Conference on Adverse Reactions Reporting Ssytems, Washington, D.C., 1970.
6.
Task Force on Prescription Drugs: United States Department of Health, Education and Welfare, Task Force on Prescription Drugs; Final report.Washington D.C.Government Printing Office, 1969.
7.
GardnerJ. W.: Forward in Pills Profits & Politics, by SilvermanM.LeeP. R., Univ. Calif. Press, Berkeley and Los Angeles, Calif., 1974.
8.
BennettW. M.SingerI.CogginsC. H.: A Practical Guide to Drug Usage in Adult Patients with Impaired Renal Function, J. Amer. Med. Assoc.214: 8: 1468 (Nov.) 1970.
9.
BennettW. M.SingerI.CogginsC. H.: Guide to Drug Usage in Adult Patients with Impaired Renal Function — A supplement, J. Amer. Med. Assoc.223: 9: 991 (Feb.) 1973.
10.
O'GradyF.: Antibiotics in Renal Failure, Brit. Med. Bull.27: 2: 1421971.
PuckettW. H.Jr.ViscontiJ. A.: An Epidemiological Study of the Clinical Significance of Drug-Drug Interactions in a Private Hospital, Amer. J. Hosp. Pharm.28: 247, (Apr.) 1971.
14.
HanstenPhillip: Drug Interactions, Lea and Febiger, Philadelphia1972.
15.
MelmonK. L., Preventable Drug Reactions — Causes and Cures, New Engl. J. Med.284: 24: 1361 (June 17) 1971.
16.
ModellWalter, The Wise Use of Drugs, J. Amer. Med. Assoc.196: 5: 129 (May 2) 1966.
17.
WintrobeM. M., The Problem of Adverse Drug Reactions, J. Amer. Med. Assoc.196: 5: 118 (May 2) 1966.
18.
U.S. News and World Report: Clampdown on the Drug Industry, Its Meaning: Washington, D. C. Vol. 76No. 25 (June 24) 2974 — page 36.
19.
National Research Council, Division of Medical Sciences, Drug Efficacy Study..
20.
MarondeR. F.BurksD.LeeP.LichtP.McCarronM.McCarryM.SeibertS.: Physician Prescribing Practices: A Computer Based Study, Amer. J. of Hosp. Pharm.26: 566 (Oct.) 1969.
21.
MarondeR.LeeP.McCarronM.SeibertS., Study of Prescribing Patterns, Medical Care9: 4 (July-Aug.) 1971.
22.
MarondeR. F., Personal communication.
23.
BarkerK. N.McConnellW. E.: The Problems of Detecting Medication Errors in Hospitals, Amer. J. Hosp. Pharm.19: 360, 1962.
24.
ThurM. P.MillerW. A.LatioliasC. J.: Medication Errors in a Nurse-Controlled Parenteral Admixture Program, Amer. J. Hosp. Pharm.29: 298, 1972.
25.
StewartR. B.CluffL. E.: A Review of Medication Errors and Compliance in Ambulant Patients, Clin. Pharmacol. Ther.13: 463, 1972.
26.
Report of Task Force on the Pharmacist's Clinical Role, J. Amer. Pharm. Assoc.NS11: 9 (Sept.) 1971.
27.
RosinskiG. F.: Strengthening Professional Competence, J. Amer. Pharm. Assoc.NS13: 403 (Aug.) 1973.
28.
FrohR. B.: The Up and Coming Roles of the Pharmacist, J. Amer. Pharm. Assoc.NS12: 8, 404, (Aug.) 1972.
29.
SilvermanM.LeeP. R.: Pills Profits & Politics, Univ. Calif. Press, Berkeley and Los Angeles, Calif.1974, p. 199.